Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico

Autores:: Bello Benavides, Ligia Alejandra

Tipo de recurso:: Article of journal

Fecha de publicación:: 2020

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_adeaecc63bc9c78be44552ab0125169f
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2883
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
dc.title.translated.eng.fl_str_mv	Drug induced cardiotoxicity: long QT syndrome with arrhythmogenic potential
title	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
spellingShingle	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico Prolongación del QT medicamentos Torsión de Puntas arritmias cardiotoxicidad QT prolongation medications Pointed Torsion arrhythmias cardiotoxicity
title_short	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
title_full	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
title_fullStr	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
title_full_unstemmed	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
title_sort	Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico
dc.creator.fl_str_mv	Bello Benavides, Ligia Alejandra
dc.contributor.author.spa.fl_str_mv	Bello Benavides, Ligia Alejandra
dc.subject.spa.fl_str_mv	Prolongación del QT medicamentos Torsión de Puntas arritmias cardiotoxicidad
topic	Prolongación del QT medicamentos Torsión de Puntas arritmias cardiotoxicidad QT prolongation medications Pointed Torsion arrhythmias cardiotoxicity
dc.subject.eng.fl_str_mv	QT prolongation medications Pointed Torsion arrhythmias cardiotoxicity
publishDate	2020
dc.date.accessioned.none.fl_str_mv	2020-03-16 00:00:00 2022-06-29T19:37:29Z
dc.date.issued.none.fl_str_mv	2020-03-16
dc.date.available.none.fl_str_mv	2020-03-16 00:00:00 2022-06-29T19:37:29Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501 http://purl.org/coar/resource_type/c_dcae04bc
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v29.n1.2020.865
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2883
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v29.n1.2020.865
identifier_str_mv	10.31260/RepertMedCir.v29.n1.2020.865 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2883 https://doi.org/10.31260/RepertMedCir.v29.n1.2020.865
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	1 Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol. 2016;67(13):1639-50. doi: 10.1016/j.jacc.2015.12.063. 2. Vlachos K, Georgopoulos S, Efremidis M, Sideris A, Letsas KP. An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol. 2016;9(1):117-27. doi: 10.1586/17512433.2016.1100073. 3. Wisniowska B, Tylutki Z, Wyszogrodzka G, Polak S. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016;17:12. doi: 10.1186/s40360-016-0053-1. 4. Villamañán E, Armada E, Ruano M. Prolongación del intervalo QT inducido por fármacos: ¿conocemos sus riesgos? Medicina Clínica. 2015;144(6):269-74. 5. Turker I, Ai T, Itoh H, Horie M. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes. Pharmacol Ther. 2017;176:48-59. doi: 10.1016/j.pharmthera.2017.05.001. 6. Poluzzi E, Raschi E, Diemberger I, De Ponti F. Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice. Drug Saf. 2017;40(6):461-4. doi: 10.1007/s40264-017-0529-y. 7. Lee A, Pickham D. Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias. Crit Care Nurs Clin North Am. 2016;28(3):357-71. doi: 10.1016/j.cnc.2016.04.007. 8. Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP. Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol. 2013;5(6):175-85. doi: 10.4330/wjc.v5.i6.175. 9. Ng TM, Olsen KM, McCartan MA, Puumala SE, Speidel KM, Miller MA, et al. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors. Journal of pharmacy practice. 2010;23(1):19-24. doi: 10.1177/0897190009356549. 10. Roden DM. Drug-induced prolongation of the QT interval. The New England journal of medicine. 2004;350(10):1013-22. doi: 10.1056/NEJMra032426. 11. Drug and Therapeutics Bulletin. QT interval and drug therapy. BMJ. 2016;353:i2732. doi: 10.1136/bmj.i2732. 12. Manini AF, Nair AP, Vedanthan R, Vlahov D, Hoffman RS. Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose. Journal of the American Heart Association. 2017;6(2). doi: 10.1161/JAHA.116.004320. 13. Hoogstraaten E, Rijkenberg S, van der Voort PH. Corrected QT-interval prolongation and variability in intensive care patients. Journal of critical care. 2014;29(5):835-9. doi: 10.1016/j.jcrc.2014.05.005. 14. Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, et al. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart rhythm. 2017;14(1):e41-e4. doi: 10.1016/j.hrthm.2016.09.012. 15. Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. The Medical clinics of North America. 2001;85(2):321-41. doi: 10.1016/s0025-7125(05)70318-7. 16. Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart rhythm. 2009;6(8 Suppl):S51-5. doi: 10.1016/j.hrthm.2009.02.009. 17. Khan IA. Long QT syndrome: diagnosis and management. American heart journal. 2002;143(1):7-14. doi: 10.1067/mhj.2002.120295. 18. Gringut S. Short QT Syndrome. In: Ferri FF, editor. Ferri's Clinical Advisor 2018. Philadelphia: Elsevier; 2018. p. 1174-5.e1. 19. Avci A, Yilmaz A, Celik M, Demir K, Keles F. Successful treatment of suicide attempt by megadose of propafenone and captopril. Cardiovascular toxicology. 2013;13(3):230-3. 20. Ari ME, Ekici F. Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report. Balkan medical journal. 2017;34(5):473-5. doi: 10.4274/balkanmedj.2016.1185. 21. Bayes de Luna A, Brugada J, Baranchuk A, Borggrefe M, Breithardt G, Goldwasser D, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. Journal of electrocardiology. 2012;45(5):433-42. 22. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. British journal of clinical pharmacology. 2016;81(3):420-7. doi: 10.1111/bcp.12726. 23. Pourmand A, Mazer-Amirshahi M, Chistov S, Sabha Y, Vukomanovic D, Almulhim M. Emergency department approach to QTc prolongation. The American journal of emergency medicine. 2017;35(12):1928-33. 24. Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 2016;149(3):139-52. doi: 10.1177/1715163516641136.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1127 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1128 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1129 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1167 https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1205
dc.relation.citationedition.spa.fl_str_mv	Núm. 1 , Año 2020 : Enero - Abril
dc.relation.citationissue.spa.fl_str_mv	1
dc.relation.citationvolume.spa.fl_str_mv	29
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía - 2020
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Revista Repertorio de Medicina y Cirugía - 2020 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf text/html application/epub+zip text/xml audio/mpeg
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/865
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/e496a420-745f-4e95-a9d9-a16979306c3b/download
bitstream.checksum.fl_str_mv	2b593d061e3f314d01fd0b7c32c82985
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355571397099520
spelling	Bello Benavides, Ligia Alejandra875ac301e62b1382553ba974c87f53e63002020-03-16 00:00:002022-06-29T19:37:29Z2020-03-162020-03-16 00:00:002022-06-29T19:37:29ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludRevista Repertorio de Medicina y Cirugía - 2020info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/865Prolongación del QTmedicamentosTorsión de PuntasarritmiascardiotoxicidadQT prolongationmedicationsPointed TorsionarrhythmiascardiotoxicityCardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénicoDrug induced cardiotoxicity: long QT syndrome with arrhythmogenic potentialapplication/pdftext/htmlapplication/epub+ziptext/xmlaudio/mpegArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v29.n1.2020.8650121-7372https://repositorio.fucsalud.edu.co/handle/001/28832462-991Xhttps://doi.org/10.31260/RepertMedCir.v29.n1.2020.865spa1 Schwartz PJ, Woosley RL. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. J Am Coll Cardiol. 2016;67(13):1639-50. doi: 10.1016/j.jacc.2015.12.063. 2. Vlachos K, Georgopoulos S, Efremidis M, Sideris A, Letsas KP. An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol. 2016;9(1):117-27. doi: 10.1586/17512433.2016.1100073. 3. Wisniowska B, Tylutki Z, Wyszogrodzka G, Polak S. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials. BMC Pharmacol Toxicol. 2016;17:12. doi: 10.1186/s40360-016-0053-1. 4. Villamañán E, Armada E, Ruano M. Prolongación del intervalo QT inducido por fármacos: ¿conocemos sus riesgos? Medicina Clínica. 2015;144(6):269-74. 5. Turker I, Ai T, Itoh H, Horie M. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes. Pharmacol Ther. 2017;176:48-59. doi: 10.1016/j.pharmthera.2017.05.001. 6. Poluzzi E, Raschi E, Diemberger I, De Ponti F. Drug-Induced Arrhythmia: Bridging the Gap Between Pathophysiological Knowledge and Clinical Practice. Drug Saf. 2017;40(6):461-4. doi: 10.1007/s40264-017-0529-y. 7. Lee A, Pickham D. Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias. Crit Care Nurs Clin North Am. 2016;28(3):357-71. doi: 10.1016/j.cnc.2016.04.007. 8. Konstantopoulou A, Tsikrikas S, Asvestas D, Korantzopoulos P, Letsas KP. Mechanisms of drug-induced proarrhythmia in clinical practice. World J Cardiol. 2013;5(6):175-85. doi: 10.4330/wjc.v5.i6.175. 9. Ng TM, Olsen KM, McCartan MA, Puumala SE, Speidel KM, Miller MA, et al. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors. Journal of pharmacy practice. 2010;23(1):19-24. doi: 10.1177/0897190009356549. 10. Roden DM. Drug-induced prolongation of the QT interval. The New England journal of medicine. 2004;350(10):1013-22. doi: 10.1056/NEJMra032426. 11. Drug and Therapeutics Bulletin. QT interval and drug therapy. BMJ. 2016;353:i2732. doi: 10.1136/bmj.i2732. 12. Manini AF, Nair AP, Vedanthan R, Vlahov D, Hoffman RS. Validation of the Prognostic Utility of the Electrocardiogram for Acute Drug Overdose. Journal of the American Heart Association. 2017;6(2). doi: 10.1161/JAHA.116.004320. 13. Hoogstraaten E, Rijkenberg S, van der Voort PH. Corrected QT-interval prolongation and variability in intensive care patients. Journal of critical care. 2014;29(5):835-9. doi: 10.1016/j.jcrc.2014.05.005. 14. Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, et al. Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? Heart rhythm. 2017;14(1):e41-e4. doi: 10.1016/j.hrthm.2016.09.012. 15. Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. The Medical clinics of North America. 2001;85(2):321-41. doi: 10.1016/s0025-7125(05)70318-7. 16. Kaufman ES. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart rhythm. 2009;6(8 Suppl):S51-5. doi: 10.1016/j.hrthm.2009.02.009. 17. Khan IA. Long QT syndrome: diagnosis and management. American heart journal. 2002;143(1):7-14. doi: 10.1067/mhj.2002.120295. 18. Gringut S. Short QT Syndrome. In: Ferri FF, editor. Ferri's Clinical Advisor 2018. Philadelphia: Elsevier; 2018. p. 1174-5.e1. 19. Avci A, Yilmaz A, Celik M, Demir K, Keles F. Successful treatment of suicide attempt by megadose of propafenone and captopril. Cardiovascular toxicology. 2013;13(3):230-3. 20. Ari ME, Ekici F. Brugada-Phenocopy Induced by Propafenone Overdose and Successful Treatment: A Case Report. Balkan medical journal. 2017;34(5):473-5. doi: 10.4274/balkanmedj.2016.1185. 21. Bayes de Luna A, Brugada J, Baranchuk A, Borggrefe M, Breithardt G, Goldwasser D, et al. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. Journal of electrocardiology. 2012;45(5):433-42. 22. Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. British journal of clinical pharmacology. 2016;81(3):420-7. doi: 10.1111/bcp.12726. 23. Pourmand A, Mazer-Amirshahi M, Chistov S, Sabha Y, Vukomanovic D, Almulhim M. Emergency department approach to QTc prolongation. The American journal of emergency medicine. 2017;35(12):1928-33. 24. Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC. 2016;149(3):139-52. doi: 10.1177/1715163516641136.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1127https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1128https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1129https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1167https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/865/1205Núm. 1 , Año 2020 : Enero - Abril129Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2702https://repositorio.fucsalud.edu.co/bitstreams/e496a420-745f-4e95-a9d9-a16979306c3b/download2b593d061e3f314d01fd0b7c32c82985MD51001/2883oai:repositorio.fucsalud.edu.co:001/28832024-02-02 13:11:57.664https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Repertorio de Medicina y Cirugía - 2020metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Cardiotoxicidad inducida por fármacos: síndrome de QT prolongado con potencial arritmogénico

Publicaciones similares